Pharma news
Americas
Novartis and Breckenridge settled their differences over a generic version of Novartis’s cancer drug Afinitor earlier this week. 10 August 2018
Pharma
A proposed change to supplementary protection certificate rules in the EU could lead to the development of less innovative medicines, according to the Irish Pharmaceutical Healthcare Association. 9 August 2018
Americas
Boehringer Ingelheim has teamed up with academic institutions and research companies in the UK to develop a long-term gene therapy for cystic fibrosis, according to a statement released on Monday, August 6. 9 August 2018
Americas
Guy Birkenmeier, previously a partner in Baker McKenzie’s IP practice group, has joined Foley Gardere as a partner in the firm’s technology transactions and outsourcing practice. 8 August 2018
Americas
Richard Gonzalez was selected in the LSIPR 50 2018 publication for his influence on the life sciences industry. He featured in the business and innovation section, as LSIPR reports. 7 August 2018
Americas
Spain-based pharmaceutical company Almirall will acquire Allergan’s dermatology portfolio. 6 August 2018
Pharma
The UK government today published four documents about how Brexit will impact the operations and regulatory status of life sciences companies. 6 August 2018
Americas
BioPharm America, to be held in Boston on September 5 and 6, 2018, will bring together startups, established companies and investors from the life sciences industry, as Kari Luu reports. 6 August 2018
Americas
Jazz Pharmaceuticals has opposed a US trademark applied for by a nutrition company to cover dietary supplements in class 5. 3 August 2018
Americas
Aggressive and exploitative patenting strategies are enabling drug makers to regularly increase prices in the US and extend monopolies, according to a new report from non-profit group the Initiative for Medicines, Access and Knowledge. 2 August 2018